What You Should Know:

你应该知道的：

–

–

Noom

诺姆

, a digital healthcare company focused on chronic disease prevention and empowering healthy living announced an agreement with

，一家专注于慢性病预防和促进健康生活的数字医疗公司，宣布与

Gifthealth

礼物健康

, the LillyDirect® pharmacy provider of Eli Lilly and Company.

，礼来公司（Eli Lilly and Company）的LillyDirect®药房提供商。

– The collaboration aims to simplify access to FDA-approved Zepbound® (tirzepatide) single-dose vials for Noom’s members who have an on-label prescription from their physician.

– 此次合作旨在简化Noom会员获取FDA批准的Zepbound®（替西帕肽）单剂量瓶的途径，这些会员需持有医生开具的符合标签用途的处方。

Evolving Noom’s Weight Management Approach:

演变Noom的体重管理方法：

This integration represents an evolution of Noom’s comprehensive approach to weight management. By enabling a streamlined solution for members prescribed FDA-approved medications, Noom is enhancing its support for those seeking effective weight management strategies. Noom has offered branded medications since 2023, and this latest integration further emphasizes the company’s commitment to a simpler and more accessible patient experience..

这种整合代表了Noom在体重管理方面的综合方法的进一步发展。通过为被开具FDA批准药物的会员提供简化的解决方案，Noom加强了对那些寻求有效体重管理策略的人的支持。自2023年以来，Noom已经开始提供品牌药物，而此次最新的整合进一步强调了公司致力于打造更简单、更便捷的患者体验。

Streamlined Access and Tracking

简化的访问和跟踪

The collaboration with LillyDirect/Gifthealth will allow Noom members with on-label prescriptions for Zepbound® vials to receive fill-status and shipping updates directly through the Noom interface. This feature aims to improve transparency and convenience for patients managing their medication.

与LillyDirect/Gifthealth的合作将允许拥有Zepbound®小瓶标示内处方的Noom会员直接通过Noom界面接收药品填充状态和运输更新。该功能旨在为管理药物的患者提高透明度和便利性。

Noom’s Comprehensive GLP-1 Companion

Noom的综合GLP-1伴侣

In addition to facilitating access to Zepbound®, Noom offers a comprehensive GLP-1 companion program to support members in making health a habit alongside the medication. This program is designed to improve treatment outcomes and persistence and includes:

除了帮助获取Zepbound®之外，Noom还提供了一项全面的GLP-1辅助计划，以支持会员在用药的同时养成健康习惯。该计划旨在改善治疗效果和持久性，包括：

GLP-1 Med Tracker:

GLP-1药物追踪器：

This feature provides reminders, a medication log, and integrated side-effect support to promote persistence and enhance weight loss outcomes.

该功能提供提醒、药物记录和综合副作用支持，以促进持续性并增强减肥效果。

Protein-focused nutrition support:

以蛋白质为重点的营养支持：

Members receive guidance and tools, including photo meal logging, to support protein intake and preserve lean mass.

会员会获得指导和工具，包括照片餐记，以支持蛋白质摄入和保持瘦体重。

Muscle Defense™ exercise plan:

肌肉防御™锻炼计划：

This plan includes personalized movement goals and accessible resistance training workouts designed to help preserve lean mass.

该计划包括个性化运动目标和旨在帮助保持瘦体质量的无障碍阻力训练。

Educational resources:

教育资源：

Noom provides tailored educational content specific to Zepbound®, including support for Zepbound® single-dose vials.

Noom 提供针对 Zepbound® 的定制教育内容，包括对 Zepbound® 单剂量小瓶的支持。

Availability

可用性

The new product integration will begin rolling out to Noom members in mid-April.

新产品整合将于四月中旬开始向Noom会员推出。

“The label on each FDA-approved GLP-1 medication makes clear they are to be used as an adjunct to a reduced-calorie diet and increased physical activity. We built Noom GLP-1 Companion with Muscle Defense™ to be that program,” said Geoff Cook, Chief Executive Officer of Noom, “which is why we are so excited for this integration.

“每种经FDA批准的GLP-1药物的标签上都明确指出，这些药物应与减少热量的饮食和增加体力活动配合使用。我们开发了Noom GLP-1伴侣产品，并配备了肌肉防御™技术，以实现这一目标，”Noom首席执行官Geoff Cook表示，“这就是为什么我们对这次整合感到如此兴奋的原因。”

We applaud Lilly’s decision to offer Zepbound® in a more affordable vial format to cash-pay patients, which aligns with Noom’s mission to empower everyone, everywhere to live better longer.”.

我们 applaud Lilly 的决定，向现金支付的患者提供更实惠的 Zepbound® 瓶装格式，这与 Noom 的使命一致，即赋予每个人、每个地方更好地延长生命的能力。"